Navigation Links
New Study Explores Impact of More Uniform Distribution of Endovascular Coils in Cerebral Aneurysm Treatment
Date:6/21/2011

RAYNHAM, Mass., June 21, 2011 /PRNewswire/ -- A new study published in the June edition of the Journal of NeuroInterventional Surgery(1) highlights that a more uniform distribution of endovascular coils may help in the treatment of cerebral aneurysms, it was reported by Codman & Shurtleff, Inc. (Codman), a global neurovascular and neuroscience company.  Codman's DELTAPAQ™ endovascular microcoils were used in the study.

Study authors found that the novel triangular primary wind design of DELTAPAQ™ endovascular microcoils achieved a tighter packing density and a more uniform distribution of the coil mass across the aneurysm dome in comparison with helical and complex endovascular microcoils.  DELTAPAQ coils were also more likely to have the highest rate of angiographic occlusion.  

Researchers concluded that the evaluation of emerging coil technologies with respect to treatment durability may be well served by an assessment of their uniformity of distribution within an aneurysm, in addition to the traditional packing density and angiographic occlusion scoring methods.  

"This study suggests that the uniformity across the dome of the aneurysm may play an important role in enhancing the durability of endovascular treatment and is an important area for further study and confirmation," said Bernard R. Bendok, MD, study co-author and Associate Professor of Neurological Surgery and Radiology at Northwestern University's Feinberg School of Medicine.*  "The application of a coil uniformity model may provide valuable design information."  

Study authors constructed silicone aneurysm models and devised an assessment tool to objectively measure the coil uniformity index, which when combined with the degree of angiographic occlusion and packing density, can provide valuable information regarding coil behavior.

In the in vitro study, DELTAPAQ coils were more uniformly distributed in the dome of t
'/>"/>

SOURCE Codman & Shurtleff, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  The need to add ... continuum was highlighted prominently at the 108 th ... (AUA), in San Diego.  According to SonaCare Medical, ... ultrasound (HIFU) technology, the need for image-guided technologies ... urologists to consider minimally invasive ablative treatments, was ...
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
(Date:5/23/2013)... 2013  Hologic, Inc. (Hologic or the Company) ... manufacturer and supplier of premium diagnostics, medical imaging ... serving the healthcare needs of women, today announced ... U.S. clinical practice comparing breast cancer screening with ... 2D mammography alone showed a significant reduction in ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
(Date:5/23/2013)... TX (PRWEB) May 23, 2013 Dr. Damon ... patients who suffer from gum disease a revolutionary new treatment ... are actually millions of Americans who suffer from periodontal disease, ... arrange for treatment. Dr. Huffman is hoping that LANAP ... periodontal disease treatment. , Periodontal disease can ...
(Date:5/23/2013)... Da Vinci surgical robot maker Intuitive ... Washington State May 23, according to Bloomberg.* The Rottenstein ... robot lawsuits , expresses disappointment in the ruling but ... not read a single verdict as representative of all ... E. Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, Superior Court, ...
(Date:5/23/2013)... Plano, TX (PRWEB) May 23, 2013 ... the Marketplace , Chaplains have been a part of ... this Memorial Day, like those preceding it, these men ... service to the United States of America. As ... trend of their migration to the workplace chaplaincy world. ...
(Date:5/23/2013)... Live Lead Pros , with ... best business lead solution via its smart solution ... solution features Free Web Based Account Management, Database ... and "Automatic Transfer Retry". The company has recently ... management system. , Its Free Database Usage offers ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a New York-based nationwide ... Information Center at http://www.rotlaw.com/tylenol , dedicated to issues ... considering filing lawsuits. , The painkiller Tylenol (acetaminophen) ... according to a 2009 report from the U.S. Food ... FDA warned consumers against using more than the recommended ...
Breaking Medicine News(10 mins):Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... osteoporosis is useful, but changes in bone// mineral density ... anti-resorptive agents that prevent bone breakdown. ,For patients ... enhances bone formation is preferable, and this is now ... However, the use of PTH is limited by its ...
... University of Bath in England an interesting study has been ... men. This is despite the popular notion that the ... yet knows. ,“Until fairly recently it was controversial to suggest ... the perception and experience of pain, but that is no ...
... issue of the journal Thorax, researchers have emphasized// the ... into the data provided by 2401 subjects who had ... incidence of tuberculosis disease. Of the total subjects ... test. The research results have showed that the increase ...
... it will promote a culture of openness and enhanced// ... FDA will create a new independent Drug Safety Oversight ... and will provide emerging information to health providers and ... ,Specific proposals for immediate and fundamental steps to improve ...
... journal Thorax a study concludes that smoking may increase ... at 2,401 adults from two urban communities in Cape Town, ... and underwent a tuberculin skin test. Factors such as age, ... into account. ,Of 1,309 current smokers or ex-smokers, ...
... Drug Administration (FDA) today issued a public health advisory ... the suspended marketing of Tysabri (nataluzimab) while the agency ... with its use., ,Tysabri, which received accelerated approval ... that represents a new approach to treating patients with ...
Cached Medicine News:Health News:The Benefits of Strontium in the treatment for Osteoporosis Questioned 2Health News:Gender difference in Pain Experience - Women feel More Pain than men 2Health News:Monitoring Drug Safety 2Health News:FDA Issues Public Health Advisory on Tysabri, a New Drug for MS 2
... Varicella-Zoster (VZ) test system ... and semi-quantitative detection of VZ ... by the indirect fluorescent antibody ... determine or confirm a recent ...
... Biotech Captia™ Varicella-Zoster Virus (VZV) ... is intended for the detection ... virus in human serum as ... of primary infection or reactivation. ...
... Captia™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked Immunosorbent ... and quantitative determination of IgG antibody to ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
ELISA kit for Varicella-zoster IgM....
Medicine Products: